Anavex Life Sciences Corp. Daily Stock Analysis

Daily Stock Analysis, AVXL, Anavex Life Sciences Corp, priceseries

Anavex Life Sciences Corp. Daily Stock Analysis
Stock Information
Open
10.28
Close
10.15
High
10.62
Low
10.12
Previous Close
10.37
Daily Price Gain
-0.22
YTD High
18.19
YTD High Date
Jan 3, 2022
YTD Low
9.28
YTD Low Date
Feb 24, 2022
YTD Price Change
-7.54
YTD Gain
-42.62%
52 Week High
31.50
52 Week High Date
Jun 28, 2021
52 Week Low
9.28
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.58
52 Week Gain
-13.47%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 27. 2017
4.22
Feb 16. 2017
5.34
14 Trading Days
26.49%
Link
LONG
Aug 18. 2017
3.93
Sep 12. 2017
4.66
16 Trading Days
18.48%
Link
LONG
Mar 2. 2018
2.60
Mar 13. 2018
2.79
7 Trading Days
7.37%
Link
LONG
May 15. 2018
2.30
Jun 22. 2018
3.90
27 Trading Days
69.43%
Link
LONG
Dec 31. 2018
1.56
Jan 15. 2019
1.83
10 Trading Days
17.15%
Link
LONG
Mar 4. 2019
2.59
Mar 28. 2019
3.14
18 Trading Days
21.32%
Link
LONG
May 14. 2019
3.15
May 24. 2019
3.33
8 Trading Days
5.57%
Link
LONG
Dec 4. 2019
3.03
Dec 5. 2019
3.24
1 Trading Days
6.93%
Link
LONG
Dec 31. 2019
2.59
Jan 22. 2020
3.06
14 Trading Days
18.17%
Link
LONG
Feb 3. 2020
3.28
Feb 24. 2020
4.63
14 Trading Days
41.26%
Link
LONG
May 18. 2020
3.73
Jun 1. 2020
4.02
9 Trading Days
7.78%
Link
LONG
Jun 15. 2020
4.08
Jul 6. 2020
4.75
14 Trading Days
16.38%
Link
LONG
Oct 16. 2020
4.84
Nov 6. 2020
5.69
15 Trading Days
17.54%
Link
LONG
Dec 14. 2020
5.19
Dec 23. 2020
5.86
7 Trading Days
12.83%
Link
LONG
Jan 27. 2021
6.03
Feb 23. 2021
11.64
18 Trading Days
93.10%
Link
LONG
May 26. 2021
12.11
Jun 29. 2021
23.86
23 Trading Days
97.05%
Link
LONG
Oct 28. 2021
18.11
Nov 10. 2021
21.46
9 Trading Days
18.48%
Link
Company Information
Stock Symbol
AVXL
Exchange
NasdaqCM
Company URL
http://www.anavex.com
Company Phone
800-689-3939
CEO
Christopher U. Missling
Headquarters
New York
Business Address
51 W 52ND STREET,, 7TH FLOOR, NEW YORK, NY 10019-6163
Sector
-
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001314052
About

Anavex Life Sciences Corp. engages in the development of differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. It's lead compound, ANAVEXTM 2-73, is being developed to treat Alzheimer's disease, Parkinson's disease, and other central nervous system diseases, including rare diseases, such as Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Description

Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of Alzheimer's disease, other central nervous system diseases, pain, and various cancers. The company's lead drug candidates include ANAVEX 2-73, a Phase 2a clinical trial for the treatment of Alzheimer's disease; and preclinical stage to treat Parkinson's disease. Its preclinical drug candidates include ANAVEX 3-71, which uses ligands that activate sigma-1 and M1 muscarinic receptors to treat Alzheimer's disease; ANAVEX 1-41, a sigma-1 agonist that protects nerve cells from degeneration or death; ANAVEX 1037 for the treatment of prostate cancer; and ANAVEX 1066, a mixed sigma-1/sigma-2 ligand for the treatment of neuropathic and visceral pain. The company was founded in 2006 and is based in New York, New York.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading